Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ilaria Testi, Aniruddha Agarwal, Rupesh Agrawal, Sarakshi Mahajan, Alessandro Marchese, Elisabetta Miserocchi & Vishali Gupta. (2020) Drug-induced Uveitis in HIV Patients with Ocular Opportunistic Infections. Ocular Immunology and Inflammation 28:7, pages 1069-1075.
Read now
Read now
Articles from other publishers (15)
Sandip Godse, Lina Zhou, Namita Sinha, Sunitha Kodidela, Asit Kumar, Udai P. Singh & Santosh Kumar. (2023) Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response. Scientific Reports 13:1.
Crossref
Crossref
Sharif Karim Sayyed, Marzuqa Quraishi, Renitta Jobby, Neelamegam Rameshkumar, Nagarajan Kayalvizhi, Muthukalingan Krishnan & Tareeka Sonawane. (2023) A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants. Archives of Microbiology 205:4.
Crossref
Crossref
Chenzhong Liao & Qin Wang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
377
390
.
Yoshitsugu Ohata, Mitsunori Tomonaga, Yasuo Watanabe, Keiko Tomura, Koji Kimura, Tatsuo Akaki, Kaoru Adachi, Eiichi N. Kodama, Yuji Matsuzaki & Hironori Hayashi. (2022) Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor JTP-0157602. Journal of Virology 96:6.
Crossref
Crossref
Majdouline El Moussaoui, Iseult Lambert, Nathalie Maes, Anne-Sophie Sauvage, Frédéric Frippiat, Christelle Meuris, Françoise Uurlings, Marianne Lecomte, Philippe Léonard, Karine Fombellida, Dolores Vaira, Christelle Vercheval, Michel Moutschen & Gilles Darcis. (2020) Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases 7:11.
Crossref
Crossref
Jianlin Han, Attila Márió Remete, Luca S. Dobson, Lorand Kiss, Kunisuke Izawa, Hiroki Moriwaki, Vadim A. Soloshonok & David O’Hagan. (2020) Next generation organofluorine containing blockbuster drugs. Journal of Fluorine Chemistry 239, pages 109639.
Crossref
Crossref
Yuqing Gong, Pallabita Chowdhury, Prashanth K. B. Nagesh, Mohammad A. Rahman, Kaining Zhi, Murali M. Yallapu & Santosh Kumar. (2020) Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages. Scientific Reports 10:1.
Crossref
Crossref
Roca Tárcio Peixoto, Lima Felipe Souza Nogueira, Santos Alcione de Oliveira, Vieira Deusilene Souza & Botelho-Souza Luan Felipo. (2019) Study of HIV Resistance Mutations Against Antiretrovirals using Bioinformatics Tools. Current HIV Research 17:5, pages 343-349.
Crossref
Crossref
Kenji Maeda, Debananda Das, Takuya Kobayakawa, Hirokazu Tamamura & Hiroaki Takeuchi. (2019) Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication. Current Topics in Medicinal Chemistry 19:18, pages 1621-1649.
Crossref
Crossref
Daniel Chastain, Melissa Badowski, Emily Huesgen, Neha Sheth Pandit, Andrea Pallotta & Sarah Michienzi. (2019) Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy. Journal of the International Association of Providers of AIDS Care (JIAPAC) 18, pages 232595821986732.
Crossref
Crossref
Pauline D.J. Bollen, Marga J.A. de Graaff-Teulen, Stein Schalkwijk, Nielka P. van Erp & David M. Burger. (2019) Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma. Journal of Chromatography B 1105, pages 76-84.
Crossref
Crossref
Najwa Alaoui, Moulay Abdelaziz El Alaoui, Nadia Touil, Hicham El Annaz, Marouane Melloul, Reda Tagajdid, Naoufal Hjira, Mohamed Boui, El Mostapha El Fahime & Saad Mrani. (2018) Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco. BMC Research Notes 11:1.
Crossref
Crossref
Sai Archana Krovi, Matthew D. Gallovic, Austin M. Keller, Menakshi Bhat, Pamela Tiet, Naihan Chen, Michael A. Collier, Elizabeth G. Gurysh, Erica N. Pino, Monica M. Johnson, M. Shamim Hasan Zahid, Mackenzie L. Cottrell, Jason R. Pirone, Angela D. Kashuba, Jesse J. Kwiek, Eric M. Bachelder & Kristy M. Ainslie. (2018) Injectable long-acting human immunodeficiency virus antiretroviral prodrugs with improved pharmacokinetic profiles. International Journal of Pharmaceutics 552:1-2, pages 371-377.
Crossref
Crossref
Eungi Choi, Jayapal Reddy Mallareddy, Dai Lu & Srikanth Kolluru. (2018) Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase. Future Science OA 4:9, pages FSO338.
Crossref
Crossref
Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, Andrea Calcagno & Antonio D'Avolio. (2018) Precision medicine for HIV: where are we?. Pharmacogenomics 19:2, pages 145-165.
Crossref
Crossref